FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannula

Article Link: FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannula

DUBLIN, Sept. 3, 2019 /PRNewswire/ — Allergan plc (NYSE: AGN) announced today it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm Voluma XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE™…

Source: FDA New Drug Approvals